Genetic testing company 23andMe had 15 million consumers who turned to them to learn more about their ancestry and understand ...

A crucial step in handling the sale of genetic data from over 15 million 23andMe customers now rests largely in the hands of ...

Most of 23andMe bought for a lot more than one could have thought–and why? Yesterday, the board of 23andMe confirmed that they have a court-approved definitive agreement for the sale of their core ...

Regeneron Pharmaceuticals acquiring genetic testing firm 23andMe for $256 million ... The acquisition includes oversight by a court-appointed, independent consumer privacy ombudsman who will ...

Regeneron Pharmaceuticals is set to acquire 23andMe for $256 million following its bankruptcy filing due to declining demand and a significant data breach in 2023. The acquisition excludes ...

Regeneron Pharmaceuticals REGN has emerged as the successful bidder in the bankruptcy auction for most of the assets of 23andMe Holding Co., a prominent player in human genetics and biotechnology.

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March, 23andMe said ...

“We assure 23andMe customers that we are committed to protecting the 23andMe dataset with our high standards of data privacy, security and ethical oversight,” said ... including the Federal Trade ...

“[W]e want to let 23andMe customer know that we are committed to protecting this dataset with our high standards of data privacy, security and ethical oversight. We believe that Regeneron has ...

Regeneron Pharmaceuticals is purchasing genetics and biotechnology company 23andMe and has vowed to protect customer data while continuing genome testing services. Regeneron announced the purchase ...

Regeneron president says that 23andMe will help further its ‘large-scale genetics research’ for drug treatments. A bankrupt 23andMe will be sold to Regeneron Pharmaceuticals, a US-based ...